Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study.

E MensionI AlonsoIsaac CebrecosN CastrejonM TortajadaI MatasS GómezL RiberaS Anglès-AcedoCamil Castelo-Branco

Published in: Climacteric : the journal of the International Menopause Society (2022)

Symptoms and physical examination regarding sexuality and vaginal health improved significantly, while serum estradiol remained at low levels. Prasterone seems a safe and effective option to treat GSM in BCS receiving AIs.

Keyphrases

mental health
public health
healthcare
physical activity
health information
estrogen receptor
health promotion
human health
newly diagnosed
risk assessment